Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Declined antibody responses to COVID-19 mRNA vaccine within first three months

View ORCID ProfilePaul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Pauliina Rumm, Regina Maruste, Jaanika Kärner, Joachim M. Gerhold, Anu Planken, Mart Ustav, Kai Kisand, Pärt Peterson
doi: https://doi.org/10.1101/2021.04.19.21255714
Paul Naaber
1SYNLAB Estonia, Tallinn, Estonia
2Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Naaber
  • For correspondence: paul.naaber{at}synlab.ee
Liina Tserel
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kadri Kangro
4Icosagen Cell Factory, Õssu, Kambja, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Epp Sepp
2Department of Microbiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virge Jürjenson
1SYNLAB Estonia, Tallinn, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ainika Adamson
1SYNLAB Estonia, Tallinn, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liis Haljasmägi
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pauliina Rumm
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regina Maruste
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaanika Kärner
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joachim M. Gerhold
4Icosagen Cell Factory, Õssu, Kambja, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anu Planken
4Icosagen Cell Factory, Õssu, Kambja, Estonia
5Department of Oncology, North-Estonian Medical Centre, Tallinn, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mart Ustav
4Icosagen Cell Factory, Õssu, Kambja, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Kisand
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pärt Peterson
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: April 2021 to May 2025

AbstractFullPdf
Apr 202121427434
May 20212044107572
Jun 20211567652732
Jul 20211304632422
Aug 20211274463266
Sep 20211068238215
Oct 2021648121113
Nov 20214839978
Dec 20212909039
Jan 20221944655
Feb 20221171425
Mar 20221301524
Apr 20221261228
May 20221131228
Jun 2022100731
Jul 2022641857
Aug 2022832219
Sep 202289824
Oct 2022109617
Nov 202265714
Dec 202277624
Jan 2023841014
Feb 2023671220
Mar 202357612
Apr 202351413
May 202332619
Jun 202323614
Jul 202329722
Aug 2023411218
Sep 2023331319
Oct 202375916
Nov 20231321130
Dec 202327512
Jan 202430128
Feb 2024341723
Mar 202429623
Apr 2024261518
May 202430617
Jun 2024321113
Jul 2024321618
Aug 2024292424
Sep 2024421312
Oct 2024251112
Nov 2024291730
Dec 2024201218
Jan 2025261127
Feb 2025273222
Mar 2025593931
Apr 2025501434
May 202523813
Back to top
PreviousNext
Posted May 25, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Declined antibody responses to COVID-19 mRNA vaccine within first three months
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Declined antibody responses to COVID-19 mRNA vaccine within first three months
Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Pauliina Rumm, Regina Maruste, Jaanika Kärner, Joachim M. Gerhold, Anu Planken, Mart Ustav, Kai Kisand, Pärt Peterson
medRxiv 2021.04.19.21255714; doi: https://doi.org/10.1101/2021.04.19.21255714
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Declined antibody responses to COVID-19 mRNA vaccine within first three months
Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Pauliina Rumm, Regina Maruste, Jaanika Kärner, Joachim M. Gerhold, Anu Planken, Mart Ustav, Kai Kisand, Pärt Peterson
medRxiv 2021.04.19.21255714; doi: https://doi.org/10.1101/2021.04.19.21255714

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)